Radiotherapy for Early-Stage Prostate Cancer in Men under 70 Years of Age
- 26 September 2015
- journal article
- Published by SAGE Publications in Tumori Journal
- Vol. 102 (2) , 209-216
Abstract
Aims: To demonstrate that radiotherapy (RT) is a valid alternative to surgery in men ≤70 years old with localized prostate cancer. Methods: From 1988 to 2009, 214 patients with T1-2 N0 M0 prostate cancer were treated with RT. The effects of patient- and treatment-related risk factors on toxicity were investigated. Results: Median follow-up was 105 months (range 14.2-180). The 5-, 10-, and 15-year biochemical relapse-free survival for all 214 patients was 80%, 61.9%, and 57.5%, respectively. In bivariate analysis, age (≤65 vs 65-70 years) was not a significant factor for biochemical relapse, while radiation dose was (p = 0.05) in multivariate analysis. Cancer-specific survival rates at 5, 10, and 15 years were 98.4%, 93.2%, and 69.7%, respectively. Median overall survival (OS) was 167 months (95% confidence interval 147.3-186.7). The OS rates at 5, 10, and 15 years were 91.8%, 75.8%, and 42.5%, respectively. Acute genitourinary (GU) and gastrointestinal (GI) toxicities occurred in 105 (49%) and 98 patients (45.8%), respectively, with only 2 cases of grade III GI toxicity. Late GU and GI toxicities occurred in 17 (7.9%) and 20 (9.3%) patients, respectively, with 1 grade III GI toxicity and 2 grade III GU toxicities. Risk factors for late toxicity were age and RT dose and technique, which were unrelated to acute toxicity. Conclusions: Age ≤70 years does not consistently confer a negative prognosis for localized prostate cancer. Radiotherapy appears to be a viable alternative to surgery, offering excellent long-term cancer control.Keywords
This publication has 29 references indexed in Scilit:
- Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trialThe Lancet Oncology, 2014
- Young age under 60years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancerRadiotherapy and Oncology, 2011
- Treatment and survival outcomes in young men diagnosed with prostate cancerCancer, 2009
- The curative role of radiotherapy in adenocarcinoma of the prostate in patients under 55 years of age: A rare cancer network retrospective studyRadiotherapy and Oncology, 2005
- Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: Year of treatment an independent predictor of outcomeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2003
- Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003Urology, 2003
- Biochemical Disease-Free Survival in Men Younger Than 60 Years With Prostate Cancer Treated With External Beam RadiationJournal of Urology, 2002
- Young patients with prostate cancer have an outcome justifying their treatment with external beam radiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
- Prostate adenocarcinoma in men younger than 50 years. A retrospective review of 151 patientsCancer, 1994
- Carcinoma of prostate in men aged fifty and under: therapeutic optionsUrology, 1992